SARS-CoV-2 Spike RBD (Bebtelovimab biosimilar) Neutralizing Antibody - E-AB-V1029 primary and hard-to-transfect cells CD163 is used as a
Pay in 4 interest-free payments of $84.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7